Peregrine Ventures

Peregrine Ventures is a prominent venture capital firm based in Or Yehuda, Israel, established in 2001. The firm specializes in cross-stage investments with a primary focus on the life sciences, digital health, enterprise software, and biotechnology sectors. Peregrine Ventures aims to support medical innovation by investing in promising companies across these industries. The firm combines extensive industry knowledge with a collaborative investment strategy, enabling its team to assist portfolio companies at various stages of development, from early seed funding to advanced growth. Peregrine Ventures is committed to providing not only financial support but also expert guidance and services that foster meaningful breakthroughs in healthcare.

Eyal Lifschitz

Co-Founder & Managing General Partner

Boaz Lifschitz

Co-Founder & Managing General Partner

Eyal Lifshitz

Managing General Partner

78 past transactions

Cordio

Venture Round in 2022
Cordio Medical LTD. develops a mobile application that provides solutions for monitoring patients with congestive heart failure deterioration. The company was formerly known as CountingApp Medical Ltd. Cordio Medical LTD. was founded in 2013 and is based in Or Yehuda, Israel.

Bluewhite

Series B in 2021
Blue White Robotics enables an autonomous future by providing ‘Robot as a Service’ - complete solution for seamless & efficient adoption of autonomous technologies on a big scale. Our software platform enables to plan and operate multiple tasks on the same location using air & ground autonomous systems fleets - UAV, drones and robotics, effectively and safely, for agriculture, mobility, security, energy & mining industries. BWR was established in 2017, by ex-IAF pilots and engineers with over 20 years of experience in unmanned and autonomous technologies. We’ve grown by 300% each year, and aim to build the world's leading operation platform of autonomous systems.

BrainQ

Venture Round in 2021
BrainQ Technolgies Ltd, a clinical-stage medtech company, develops brain-machine induction technologies to provide personalized, safe, and noninvasive treatments for neuro-disorders including stroke, traumatic brain injury, and spinal cord injury. It offers a cloud-based medical device that utilizes artificial intelligence to analyze patients’ EEG sensor data. The company was founded in 2011 and is based in Jerusalem, Israel.

Aleph Farms

Series B in 2021
Aleph Farms Limited, based in Ashdod, Israel, specializes in the production of clean meat through innovative cellular agriculture techniques. The company focuses on growing real beef steaks and other meat products directly from the cells of living cows, utilizing proprietary three-dimensional bioprinting technologies. This approach allows Aleph Farms to create lab-cultured meat products, including ground meat and beef burger patties, without the need for animal slaughter. As a leader in the sustainable food ecosystem, Aleph Farms aims to reshape the global meat market, which is valued at over $1 trillion. Co-founded with The Kitchen Hub and the Technion Institute of Technology, Aleph Farms has garnered significant investment to support its mission to provide clean and healthy alternatives to traditional meat products.

Aleph Farms

Series B in 2021
Aleph Farms Limited, based in Ashdod, Israel, specializes in the production of clean meat through innovative cellular agriculture techniques. The company focuses on growing real beef steaks and other meat products directly from the cells of living cows, utilizing proprietary three-dimensional bioprinting technologies. This approach allows Aleph Farms to create lab-cultured meat products, including ground meat and beef burger patties, without the need for animal slaughter. As a leader in the sustainable food ecosystem, Aleph Farms aims to reshape the global meat market, which is valued at over $1 trillion. Co-founded with The Kitchen Hub and the Technion Institute of Technology, Aleph Farms has garnered significant investment to support its mission to provide clean and healthy alternatives to traditional meat products.

KAHR medical

Venture Round in 2021
KAHR medical Ltd., an immuno-oncology drug development company, develops and manufactures fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. It offers DSP105 and DSP 106 that are used for T-cell mediated tumor destruction; and DSP 107 that targets CD47 tumors activating phagocytes and delivering an immune costimulatory signal. The company was founded in 2005 and is based in Jerusalem, Israel.

Ribon Therapeutics

Series C in 2021
Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, founded in 2015. The company is focused on developing innovative cancer therapies that target monoPARP proteins, which are essential regulators of cancer cell survival. Ribon's scientific founders have made significant contributions to the understanding of PARPs, or poly(ADP-ribose) polymerases, and their roles in cancer. Leveraging this expertise, Ribon is establishing a proprietary drug discovery platform aimed at exploring the molecular actions and biological functions of monoPARPs. This platform supports the creation of a pipeline of therapeutics that selectively target these proteins to potentially treat cancer and other diseases. Ribon Therapeutics is supported by notable life science investors, enhancing its capability to advance its research and development efforts.

Memic Innovative Surgery

Series D in 2021
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Memic Innovative Surgery

Series D in 2021
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

OutSense

Series A in 2020
OutSense Diagnostics develops a medical device for early detection of medical conditions. The company’s product analyzes and diagnoses human waste from within a standard toilet bowl and alerts caregivers of health deviations. It can be used for early detection of various applications, such as colorectal cancer, urinary tract infection; diarrhea; dehydration; and constipation. OutSense Diagnostics was founded in 2016 and is based in Or Yehuda, Israel.

BioProtect

Series D in 2020
BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CE marked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.

Bluewhite

Series A in 2020
Blue White Robotics enables an autonomous future by providing ‘Robot as a Service’ - complete solution for seamless & efficient adoption of autonomous technologies on a big scale. Our software platform enables to plan and operate multiple tasks on the same location using air & ground autonomous systems fleets - UAV, drones and robotics, effectively and safely, for agriculture, mobility, security, energy & mining industries. BWR was established in 2017, by ex-IAF pilots and engineers with over 20 years of experience in unmanned and autonomous technologies. We’ve grown by 300% each year, and aim to build the world's leading operation platform of autonomous systems.

Payzday

Series B in 2020
Payzday is a risk management solution provider based in Tel Aviv, Israel, established in 2017. The company specializes in analyzing the risk levels of merchants selling online through marketplaces. By leveraging advanced technologies such as big data, artificial intelligence, and predictive analytics, Payzday creates significant visibility into the risk associated with these merchants. Its approach extends beyond initial onboarding assessments, offering continuous monitoring that enables near real-time predictions of any potentially unlawful, risky, or unstable situations involving merchants. This innovative methodology allows financial institutions to make informed decisions and provide necessary financing solutions to online sellers, ultimately aiming to enhance their access to capital.

Hairstetics

Convertible Note in 2020
Hairstetics Ltd. engages in the development, manufacturing and marketing of innovative hair restoration devices. The company was founded in 2010 and is based in Omer, Israel.

SinuSafe Medical

Convertible Note in 2020
SinuSafe Medical develops a nano-debrider device for sinuses irrigating and aspirating without surgical intervention. The device implants bone between the lining and maxillary sinus in the upper jaw, allowing patients to get rid of sinus problems. SinuSafe Medical was founded in 2014 and is headquartered in Tel Aviv, Israel.

Restore Medical

Series A in 2020
Restore Medical develops and provides a device-based therapy for congestive heart failure. It improves patient quality of life and reduce hospital readmission rates. Restore Medical's product, ContraBand, is a novel catheter-delivered implant in the pulmonary arteries for treatment of left ventricle failure, for patients with preserved right ventricle function. Restore Medical was founded in 2016 and is headquartered in Or Yehuda, Israel.

Raziel Health

Series C in 2019
Raziel Health, founded in 2012 and based in Rehovot, Israel, focuses on transforming healthcare delivery by providing accessible and cost-effective solutions for patients in their homes. The company integrates user-friendly technologies that enhance patient experiences and facilitate timely clinical interventions tailored to individual needs. By leveraging data analytics, Raziel Health supports wellness and disease management, aiming to improve health outcomes while making healthcare more affordable. In addition to its healthcare services, Raziel is developing RZL-012, a novel synthetic small molecule designed for obesity treatment, which works by inducing fat cell death at the injection site to reduce fat tissue.

Roby.AI

Series A in 2019
Roby offers an artificial intelligence assistant for rental agencies and property managers. It an autonomous machine that requires only a few human interventions and is able to execute across all the different tasks involved in property management. Roby utilizes push notifications via SMS and email to invite users and their clients to engage with the rental process. It reduces manual tasks, streamlines workflow, improves compliance, and reduces costs.

Aleph Farms

Series A in 2019
Aleph Farms Limited, based in Ashdod, Israel, specializes in the production of clean meat through innovative cellular agriculture techniques. The company focuses on growing real beef steaks and other meat products directly from the cells of living cows, utilizing proprietary three-dimensional bioprinting technologies. This approach allows Aleph Farms to create lab-cultured meat products, including ground meat and beef burger patties, without the need for animal slaughter. As a leader in the sustainable food ecosystem, Aleph Farms aims to reshape the global meat market, which is valued at over $1 trillion. Co-founded with The Kitchen Hub and the Technion Institute of Technology, Aleph Farms has garnered significant investment to support its mission to provide clean and healthy alternatives to traditional meat products.

Payzday

Seed Round in 2018
Payzday is a risk management solution provider based in Tel Aviv, Israel, established in 2017. The company specializes in analyzing the risk levels of merchants selling online through marketplaces. By leveraging advanced technologies such as big data, artificial intelligence, and predictive analytics, Payzday creates significant visibility into the risk associated with these merchants. Its approach extends beyond initial onboarding assessments, offering continuous monitoring that enables near real-time predictions of any potentially unlawful, risky, or unstable situations involving merchants. This innovative methodology allows financial institutions to make informed decisions and provide necessary financing solutions to online sellers, ultimately aiming to enhance their access to capital.

Kymera Labs

Seed Round in 2018
Kymera Labs develops synthetic data to securely process your confidential information.

Restore Medical Solutions

Series A in 2018
Restore Medical Solutions is a medical device company focusing on products and techniques that promote SSI reduction, safety, and productivity within healthcare. The company manufactures a sterilization tray system that reduces the risk of infection from contaminated medical instruments. Its modular sterilization tray systems reduce the potential risk of infection from contaminated instruments and enable surgical departments to improve the quality of care while reducing cost. Founded in 2012, Restore Medical Solutions is headquartered in Memphis, Tennessee.

Memic Innovative Surgery

Series C in 2018
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Hairstetics

Seed Round in 2018
Hairstetics Ltd. engages in the development, manufacturing and marketing of innovative hair restoration devices. The company was founded in 2010 and is based in Omer, Israel.

CliClap

Series A in 2018
CliClap LTD develops content marketing utility for web browsers. It enables users to boost audience engagement, brand awareness and drive business goals. Additionaly, the products add users call to action, schedule their posts, analyze the success. The company was founded in 2016 and is based in Kfar Saba, Israel.

CliClap

Seed Round in 2018
CliClap LTD develops content marketing utility for web browsers. It enables users to boost audience engagement, brand awareness and drive business goals. Additionaly, the products add users call to action, schedule their posts, analyze the success. The company was founded in 2016 and is based in Kfar Saba, Israel.

Payzday

Seed Round in 2017
Payzday is a risk management solution provider based in Tel Aviv, Israel, established in 2017. The company specializes in analyzing the risk levels of merchants selling online through marketplaces. By leveraging advanced technologies such as big data, artificial intelligence, and predictive analytics, Payzday creates significant visibility into the risk associated with these merchants. Its approach extends beyond initial onboarding assessments, offering continuous monitoring that enables near real-time predictions of any potentially unlawful, risky, or unstable situations involving merchants. This innovative methodology allows financial institutions to make informed decisions and provide necessary financing solutions to online sellers, ultimately aiming to enhance their access to capital.

Cordio

Series B in 2017
Cordio Medical LTD. develops a mobile application that provides solutions for monitoring patients with congestive heart failure deterioration. The company was formerly known as CountingApp Medical Ltd. Cordio Medical LTD. was founded in 2013 and is based in Or Yehuda, Israel.

Cordio

Series A in 2017
Cordio Medical LTD. develops a mobile application that provides solutions for monitoring patients with congestive heart failure deterioration. The company was formerly known as CountingApp Medical Ltd. Cordio Medical LTD. was founded in 2013 and is based in Or Yehuda, Israel.

Digma Medical

Series B in 2016
Digma Medical is a clinical stage medical device company established in 2013, focused on innovating treatments for Type-2 Diabetes and related metabolic syndromes, including NASH. The company is developing the DiaGone™, an endoscopic and disposable device that employs advanced laser technology to treat the duodenum without the need for an implant. The Duodenal Glycemic Control™ procedure, which lasts approximately 30 minutes, allows gastroenterologists to use the DiaGone™ to enhance the body's ability to regulate glucose levels. This approach aims to offer patients the potential for long-term remission from Type-2 Diabetes and other metabolic conditions, thereby improving their overall quality of life and health outcomes. Supported by prominent venture capital firms, Digma Medical is dedicated to advancing effective therapies for diabetes management.

Rise.ai

Seed Round in 2016
Rise.ai is a strategic re-engagement solution that provides brands and retailers with a unique currency of their own. Powered by Artificial Intelligence, Rise.ai helps merchants grow by retaining customers and increasing their average spending.

OutSense

Seed Round in 2016
OutSense Diagnostics develops a medical device for early detection of medical conditions. The company’s product analyzes and diagnoses human waste from within a standard toilet bowl and alerts caregivers of health deviations. It can be used for early detection of various applications, such as colorectal cancer, urinary tract infection; diarrhea; dehydration; and constipation. OutSense Diagnostics was founded in 2016 and is based in Or Yehuda, Israel.

NeuroApplied

Seed Round in 2016
NeuroApplied offers customer-focused marketing based on the study of the customers’ collective subconscious. The company applies machine-learning analytics, in combination with neural-networks computing, to online picture games in order to provide its clients with useful data collected from the associative subconscious of their customers. Its SaaS-based platform provides an intuitive dashboard for insights that is nonintrusive, and visually stimulating for respondents. NeuroApplied was founded by Lior Moyal, Elhanan Meirovithz, and Inna Schneiderman in June 2016.

Eximo Medical

Series C in 2016
Eximo Medical Ltd. develops hybrid catheter technology for tissue resection invascular and gastrointestinal endoluminal applications. The company’s technology includes CatHI, a single-use hybrid catheter that provides optical fibers that deliver short laser pulse, and a blunt mechanical knife. Its clinical applications also comprise lead extraction and peripheral artery disease. The company was founded in 2012 and is based in Modi'in-Maccabim-Re'ut, Israel. As of October 2, 2019, Eximo Medical Ltd. operates as a subsidiary of AngioDynamics, Inc.

Restore Medical Solutions

Seed Round in 2016
Restore Medical Solutions is a medical device company focusing on products and techniques that promote SSI reduction, safety, and productivity within healthcare. The company manufactures a sterilization tray system that reduces the risk of infection from contaminated medical instruments. Its modular sterilization tray systems reduce the potential risk of infection from contaminated instruments and enable surgical departments to improve the quality of care while reducing cost. Founded in 2012, Restore Medical Solutions is headquartered in Memphis, Tennessee.

SinuSafe Medical

Seed Round in 2016
SinuSafe Medical develops a nano-debrider device for sinuses irrigating and aspirating without surgical intervention. The device implants bone between the lining and maxillary sinus in the upper jaw, allowing patients to get rid of sinus problems. SinuSafe Medical was founded in 2014 and is headquartered in Tel Aviv, Israel.

mPharma

Seed Round in 2016
mPharma Data, Inc. is a technology-driven company based in Accra, Ghana, with an additional location in Lexington, Massachusetts. Founded in 2013, it focuses on improving access to high-quality medications in emerging markets by connecting physicians, pharmacies, and patients through its application. The company aggregates real-time market data on prescription trends, drug consumption, and adverse reactions, providing valuable insights to pharmaceutical manufacturers, distributors, and governments. mPharma offers a pharmacy network application that centralizes inventories from multiple pharmacies, enabling easier drug searches for physicians and patients. Additionally, the company provides subscription-based data analytics for actionable insights on drug consumption and diagnosis, along with prescription management tools to assist healthcare providers in locating various medicines. By partnering with drug manufacturers, insurance companies, and governments, mPharma aims to facilitate affordable access to essential medications for patients.

Memic Innovative Surgery

Series A in 2015
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Memic Innovative Surgery

Seed Round in 2015
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Evolero

Seed Round in 2015
Evolero Ltd. specializes in event management software solutions tailored for event organizers and meeting planners. Founded in 2011 and headquartered in Herzliya, Israel, the company provides a comprehensive platform that facilitates online conference planning and organization. Evolero's software enables users to sell tickets online, manage event ticketing and registration, and offers sponsors advanced marketing tools. Additionally, it equips attendees with networking capabilities, all within a single platform. By integrating various functionalities, Evolero supports meeting planners and congress organizers in creating effective event websites and enhancing social media engagement for improved networking opportunities.

Cordio

Seed Round in 2014
Cordio Medical LTD. develops a mobile application that provides solutions for monitoring patients with congestive heart failure deterioration. The company was formerly known as CountingApp Medical Ltd. Cordio Medical LTD. was founded in 2013 and is based in Or Yehuda, Israel.

Yotta Green

Seed Round in 2014
Yotta Green offers an innovative smart home system that focuses on improving energy efficiency, comfort, and safety through advanced monitoring technologies. By analyzing household power consumption and learning consumer behavior patterns, the system provides valuable insights into energy usage. It alerts users to potential energy waste and electrical hazards, such as fires, and can automatically turn off unused lights and appliances. Additionally, the system can take proactive measures, like lowering blinds before a storm, to enhance home safety. Yotta Green's user-friendly interface, accessible via a smartphone app along with touch and gesture activation devices, ensures maximum convenience for homeowners seeking to optimize their energy consumption and maintain a secure living environment.

ShapeDo

Pre Seed Round in 2014
ShapeDo develops software that helps manage plan changes in construction projects. The system ensures that plan changes are accounted for in contracts, budgets, and other agreements. ShapeDo's software tracks blueprint versions, compares versions, and facilitates creation of court-ready pricing reports, requests for information (RFIs), and claims. ShapeDo has been involved in major infrastructure projects, such as a new international airport, an underground train, hospitals, and data centers. The system can also be used in smaller commercial and residential projects.

NitiNotes

Seed Round in 2013
Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.

Zuznow

Seed Round in 2013
Zuznow specializes in mobile adaptation solutions for websites, providing a platform that automatically analyzes and adjusts the visual structure of desktop sites for optimal viewing on smartphones. Founded in 2009 and based in Israel, the company serves a diverse clientele, including notable names such as VentureBeat, HOOP, Newsgeek, and BAKER TILLY. Zuznow's rapid mobile application development (RMAD) platform operates as a Front-end-as-a-Service (FAAS), facilitating the creation of secure mobile applications for B2B, B2C, and B2E enterprises. This hybrid platform is designed to streamline the adaptation of complex websites, significantly reducing development time and costs while meeting the increasing demand for mobile functionality.

MarketYze

Seed Round in 2012
Marketyze is a technology company that offers semantic site search and online price comparison solutions ground on deep domain expertise. Catering to the retail industry, the company’s pricing intelligence software tracks and analyzes pricing, and market and internal data to discover how pricing events can affect company sales performance. This in turn empowers companies to fine tune their pricing policies to maximize both sales and profits. Marketyze was founded by Onn Manelson and Nave Ronen in December 2011 and is based in Israel.

Evolero

Seed Round in 2012
Evolero Ltd. specializes in event management software solutions tailored for event organizers and meeting planners. Founded in 2011 and headquartered in Herzliya, Israel, the company provides a comprehensive platform that facilitates online conference planning and organization. Evolero's software enables users to sell tickets online, manage event ticketing and registration, and offers sponsors advanced marketing tools. Additionally, it equips attendees with networking capabilities, all within a single platform. By integrating various functionalities, Evolero supports meeting planners and congress organizers in creating effective event websites and enhancing social media engagement for improved networking opportunities.

NLT SPINE

Venture Round in 2012
NLT SPINE, a clinical stage VC-backed company, specializes in the development and marketing of innovative Minimally Invasive Spinal Surgery (MISS) products for treating degenerative spinal conditions. The company's vision is to improve patient care by shifting from traditional open surgical routines to MISS, employing new methods and technologies to enhance safety, predictability and outcomes.

ArTack Medical

Seed Round in 2012
ArTack Medical is a privately held medical device company that develops tools for the invasive surgery market. The tools are based on ArTack Medical's patented drive platform, which allows the delivery of torque through a 5mm shaft. ArTack Medical was founded on 2013 and is headquartered in Haifa, Israel.

Mend

Seed Round in 2011
WhiteSource is the leading solution for agile open source security and license compliance management. It integrates with your development environments and DevOps pipeline to detect open source libraries with security or compliance issues in real-time. WhiteSource doesn’t only alert on issues, it also provides actionable, validated remediation paths to enable quick resolution and automated policy enforcement to speed up time-to-fix. It also helps you focus on what matters by prioritizing remediation based on whether your code is actually using a vulnerable method or not, and guaranteeing zero false positives. We've got you covered with support for over 200 programming languages, and continuous tracking of multiple open source vulnerabilities databases including the NVD, security advisories, peer-reviewed vulnerability knowledge bases, and open source projects issue trackers.

CartiHeal

Series C in 2011
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

Peak-Dynamics

Seed Round in 2011
Peak-Dynamics is a research-driven hi-tech company that addresses the complexity of operating a water utility, charged with maintaining reliability of service and assuring water quality, while minimizing energy and other operational costs. Its groundbreaking software system, PeakWater, and innovative OSSA (Optimized Stochastic Search Algorithm) technology, offers water utility management and operations personnel means to realize significant energy savings. Starting out in a technological incubator, Peak-Dynamics emerged to become a member of the MER Group with its innovative system, PeakWater, representing a new level of water utility management. Overlooking and interfacing with the SCADA system from which it collects current and historic data, it monitors and controls the energy efficiency aspects of the network's operation. A uniquely new feature introduced by the system involves a comparative analysis of energy supplier tariffs. Ensuring compliance with contractual demands and constraints, PeakWater allows water authorities to take advantage of the increasingly open private energy market. No other available system includes this considerable cost-saving option. Combining optimized water system management with optimized leverage of energy tariffs, Peak-Dynamics seeks to usher utilities to a new level of operations in the era of the Water-Energy Nexus. Marketing its solution to water system management companies and integrators, as well as to municipal, regional and national water authorities, it offers previously unattainable levels of reliability and cost savings. Peak-Dynamics is manned by a team of highly educated and skilled personnel from software developers through seasoned hi-tech entrepreneurs and experts in international sales activities, to renowned business consultants, R&D managers and experts in the field of water system modeling and pricing decisions. Poised for growth, the company has recently established representation in the US.

Eximo Medical

Seed Round in 2011
Eximo Medical Ltd. develops hybrid catheter technology for tissue resection invascular and gastrointestinal endoluminal applications. The company’s technology includes CatHI, a single-use hybrid catheter that provides optical fibers that deliver short laser pulse, and a blunt mechanical knife. Its clinical applications also comprise lead extraction and peripheral artery disease. The company was founded in 2012 and is based in Modi'in-Maccabim-Re'ut, Israel. As of October 2, 2019, Eximo Medical Ltd. operates as a subsidiary of AngioDynamics, Inc.

CardioGard Medical

Seed Round in 2011
CardioGard develops a specially designed arterial cannula for the removal of gaseous material during heart bypass surgeries. The system is composed of a double-lumen cannula in which the primary lumen provides oxygenated blood from the heart-lung machine to the patient and a secondary lumen suctions blood and embolic matter away from the surgical field and back to the cardiopulmonary bypass machine for the filtration.

Valire

Seed Round in 2010
Valire is a software solution company that specializes in the field of artificial intelligence. It features fraud risk assessment, business process validation, and algorithm development that helps businesses, companies, and organizations to secure their revenue. The company was founded in 2009 and headquartered in HaMerkaz, Israel.

Otic Pharma

Seed Round in 2010
Otic Pharma is a clinical-stage pharmaceutical company focusing on the development and commercialization of products for disorders of the ear, nose, and throat (ENT). The company has two platform technologies, each of which has the potential to be developed for multiple ENT indications. The company is currently developing a nasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD), a condition that affects more than 700 million people around the world every year. Otitis media is one of the most common disease seen in pediatric practice and the most frequent reason children consume antibiotics or undergo surgery. The company also has a foam-based drug delivery technology platform (OP-01) that can be used to deliver drugs into the ear, nose, and sinus cavities. The company is currently developing OP-01 as an improved treatment option for acute otitis externa (“swimmers ear”). For more information on the company, please visit www.oticpharma.com

Quicklizard

Seed Round in 2010
Quicklizard offers the ultimate dynamic pricing platform for e-commerce and omnichannel retailers. With QL, you can monitor, calculate and apply optimal prices based on real-time market trends. Our AI platform continuously tracks and analyzes multiple data sources, adjusting prices so you stay profitable and competitive at the same time. We collect information from competitive landscapes, customer journey, and demand trends. By actively adapting to changes in the market, you can set the right prices to maximize sales volume and increase revenue by up to 30%. Quicklizard seamlessly integrates with most commerce, retail and ERP platforms, while automatically syncing pricing recommendations.

Rocketick

Seed Round in 2010
Rocketick Technologies Ltd., founded in 2008 and based in Ramat Gan, Israel, specializes in GPU-based simulation acceleration solutions aimed at enhancing chip verification processes. The company's flagship product, RocketSim, is a software-based simulation engine that integrates within existing simulator environments. It effectively addresses functional verification bottlenecks by providing GPU acceleration, resulting in simulations that are up to ten times faster for complex designs. RocketSim has gained traction among various semiconductor clients, establishing Rocketick as a pioneer in the field of hardware-assisted acceleration. Since April 2016, Rocketick has operated as a subsidiary of Cadence Design Systems Inc.

CartiHeal

Series A in 2009
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

Cellvine

Seed Round in 2008
Cellvine develops and markets innovative coverage and capacity solutions for the wireless telecommunications industry. Cellvine's broad range of cellular coverage enhancement products and solutions are based on its exclusive technology for improving cellular signals for in-building, urban and rural over-ground and subterranean environments such as mines and tunnels.

Valtech Cardio

Seed Round in 2007
Valtech Cardio (Israel) a development-stage medical device company focused on minimally invasive percutaneous annuloplasty ring valve repair for the treatment of mitral valve regurgitation.

Kailight Photonics

Series B in 2006
Kailight Photonics develops optical modules for the telecommunications industry. It offers tunable optical signal regenerator, an optical component that operates with regenerators, optical switches, add/drop multiplexers, and cross-connects. The company's optical transmission, signal regeneration, and wavelength conversion technology provides optical-networking solutions for systems vendors. It provides its products to long-haul network market segments. The company, formerly known as Chilight Technologies, was founded in 2000 and is headquartered in Rehovot, Israel with an additional office in Dallas, Texas. As of May 15, 2007, Kailight Photonics, Inc. operates as a subsidiary of Optium Corporation.

Neovasc

Seed Round in 2006
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Topspin Medical

Series B in 2002
TopSpin Medical developed an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI setup. The catheter contains those components, which are usually found in a conventional MRI scanner, only that they are miniaturized to less than 2 millimeters in size.
VisionCare Ophthalmic Technologies, Inc. operates as a specialty medical device company that engages in the research, development, manufacture, and marketing of implantable ophthalmic devices, and technologies that are intended to improve vision for individuals with untreatable retinal disorders. The company offers Implantable Miniature Telescope (IMT), an implantable medical device to improve vision and quality of life in individuals with end-stage age-related macular degeneration (AMD). Its telescope implant is integral to the CentraSight treatment program, which has been developed to help patients follow the necessary steps for proper diagnosis, surgical evaluation, and postoperative care. VisionCare Ophthalmic Technologies, Inc. was founded in 1997 and is based in Saratoga, California.